NYSEConsumer DiscretionarySpecialty RetailSnapshot 2026-07-09
Reading BOBS? Create a free portfolio, then add this holding for ongoing Reports and tracking. No credit card.
Create your account →Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Consumer Discretionary is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Management is running behind on a stated commitment.
View ThesisThis stock is highly volatile — it swings about 3% on a typical day and fell roughly 56% in its worst 12-month stretch.
View RiskBOBS must maintain its growth trajectory through expansion efforts to justify its current valuation. Revenue growth is supported by the recent expansion into Tennessee and the reaffirmation of full fiscal year 2026 guidance. The stock trades at a valuation that appears roughly in line with its peers, indicating that the market has priced in the expected growth. A specific risk is that if BOBS cuts guidance on the next call, it could lead to a significant decline, as the Street often lowers estimates in response. Peer multiples imply a price roughly in line with where it trades. This read is provisional.
Trailing returns as of 2026-07-10. BOBS is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 13 analysts currently covering BOBS (as of Jul 2026).
Based on 3 Wall Street analysts offering 12-month price targets for BOBS in the last 4 months.
A consensus fair price across 2 valuation methods, at three horizons. As of 2026-07-11. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Other Specialty Retail — fair value, gap to price, and forward P/E.
Advances: Reaffirm full fiscal year 2026 guidance
Expansion supports growth objectives for fiscal year 2026.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-07-10. EPS is implied from price ÷ P/E. Not investment advice.
Current $15.65
The last 12 months of price, then the range of analyst 12-month targets from today’s $15.65.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Improving financials support full fiscal year guidance.
Threatens: Reaffirm full fiscal year 2026 guidance
Downgrade indicates potential challenges to growth.
